Chalothorn Wannaphut

10PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthSocio-economic developmentApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 27, 2026
Real-world outcomes of nivolumab-AVD and brentuximab vedotin-AVD in paediatric and adult advanced-stage Hodgkin lymphoma.

|Jul 24, 2026
KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations.

|Jan 27, 2026
Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer.

Dileep Reddy Rampa, Minji Seo, Nanae Ogata

|Dec 06, 2025
Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis.

Chalothorn Wannaphut, Piyatida Chumnumsiriwath, Stefan O Ciurea

|Aug 18, 2025
Racial disparities in non-small cell lung cancer survival outcomes: a systematic review and meta-analysis.

Chalothorn Wannaphut, Ben Ponvilawan, Chanakarn Kanitthamniyom

|Apr 28, 2025
Concurrent Thyroid Storm From Postpartum Thyroiditis and Lymphocytic Hypophysitis: A Rare Case.

Chalothorn Wannaphut, Sakditad Saowapa, Vitchapong Prasitsumrit

Pageof 2

Frequent Collaborators

4 joint publications

Sakditad Saowapa

2 joint publications

Phuuwadith Wattanachayakul

2 joint publications

Natchaya Polpichai

2 joint publications

Manasawee Tanariyakul